⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PHAR News
Pharming Group N.V. ADS, each representing 10 ordinary shares
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
accessnewswire.com
PHAR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
prnewswire.com
PHAR
Pharming Group to report fourth quarter and full year 2025 financial results and provide business update on March 12
globenewswire.com
PHAR
PHARM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
accessnewswire.com
PHAR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
globenewswire.com
PHAR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
accessnewswire.com
PHAR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
accessnewswire.com
PHAR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
accessnewswire.com
PHAR
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pharming Group N.V. (PHAR) And Encourages Shareholders to Reach Out
accessnewswire.com
PHAR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
accessnewswire.com
PHAR